Phospho-LAT (Y191) Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Characteristics

  • Type: Monoclonal or polyclonal antibodies, with recombinant variants available (e.g., rabbit IgG) .

  • Immunogen: Synthesized peptides derived from phosphorylated Y191 of human LAT .

  • Reactivity:

    • Species: Human, Mouse, Rat .

    • Tissue expression: LAT is found in T-cells, natural killer cells, mast cells, platelets, and leukemic cells .

  • Form: Liquid or lyophilized, with storage recommendations at -20°C or 4°C .

ManufacturerClonalityApplicationDilution Range
Boster BioMonoclonalWB, IHC, IF, IPWB: 1:500–1:2000
CusabioRecombinantWB, IHC, IF, IPWB: 1:500–1:5000
AbcamPolyclonalWB, IHC-P, ELISAWB: 1:500

Western Blotting (WB)

  • Detects phosphorylated LAT in lysates of activated T-cells (e.g., Jurkat cells) .

  • Observed band size: ~28 kDa (consistent with LAT’s molecular weight) .

Immunohistochemistry (IHC)

  • Demonstrates LAT phosphorylation in tissue sections (e.g., colon carcinoma) .

  • Optimal dilution: 1:50–1:200 .

Immunofluorescence (IF)

  • Visualizes membrane-associated LAT in T-cells and platelets .

  • Dilution: 1:50–1:200 (Boster) or 1:20–1:200 (Cusabio) .

Immunoprecipitation (IP)

  • Enriches phosphorylated LAT for downstream signaling complex analysis .

Validation and Specificity

  • Positive Controls: Jurkat cells treated with CD3/CD28 activators .

  • Blocking Peptide: Available for specificity verification .

  • Cross-reactivity:

    • Human, Mouse, Rat (validated) .

    • Potential pig reactivity (untested but predicted based on homology) .

T-Cell Signaling

  • LAT phosphorylation (Y191, Y171, Y226) recruits signaling molecules (e.g., PLC-γ1, GRB2) to mediate calcium mobilization and MAPK activation .

  • Dysregulation linked to immunodeficiency and leukemia .

Disease Applications

  • Oncology: LAT hyperactivation in T-cell acute lymphoblastic leukemia (T-ALL) .

  • Inflammatory Disorders: LAT phosphorylation in mast cell degranulation and cytokine release .

Diagnostic Potential

  • PSSAs like Phospho-LAT (Y191) enable spatial and temporal analysis of signaling events in tissues, aiding cancer therapy monitoring .

Product Specs

Buffer
The antibody is provided as a liquid solution in phosphate-buffered saline (PBS) containing 50% glycerol, 0.5% bovine serum albumin (BSA), and 0.02% sodium azide.
Form
Liquid
Lead Time
Typically, we can ship your order within 1-3 business days of receiving it. Delivery time may vary depending on the purchase method or location. Please consult your local distributor for specific delivery times.
Synonyms
LAT; Linker for activation of T-cells family member 1; 36 kDa phospho-tyrosine adapter protein; pp36; p36-38
Target Names
LAT
Uniprot No.

Target Background

Function
Phospho-LAT (Y191) Antibody targets the phosphorylated form of the Linker for Activation of T cells (LAT) protein at tyrosine residue 191. LAT is a critical signaling molecule involved in T-cell receptor (TCR) and pre-TCR-mediated signaling pathways. These pathways are essential for both mature T-cell function and T-cell development. Furthermore, LAT plays a role in signaling events initiated by FcγRIII (low affinity immunoglobulin gamma Fc region receptor III) in natural killer cells and by FcεRI (high affinity immunoglobulin epsilon receptor) in mast cells. LAT acts as a crucial adaptor protein, linking the activation of these receptors and their associated kinases to downstream signaling events, including mobilization of intracellular calcium stores, activation of protein kinase C (PKC) and mitogen-activated protein kinases (MAPKs), and reorganization of the cytoskeleton. This intricate function is achieved through the recruitment of various signaling molecules, including phospholipase C gamma 1 (PLCG1), growth factor receptor-bound protein 2 (GRB2), GRAP2, and others.
Gene References Into Functions
  1. Plasma membrane LAT activation precedes vesicular recruitment, defining two distinct phases in the early stages of T-cell activation. PMID: 29789604
  2. Overexpression of LAT1, a member of the LAT family, is associated with a poor prognosis in cancer. It is linked to tumor grade, proliferative potential, angiogenesis, and mediates intracellular transport of anticancer agents. PMID: 28815339
  3. The cooperative binding of the GRB2 family to LAT, dependent on dimerization, enhances antigen receptor sensitivity. This occurs by reducing signalosome formation at incompletely phosphorylated LAT molecules, prioritizing the formation of complete signalosomes. PMID: 28951535
  4. Nur77, a transcription factor, suppresses CD4(+) T cell proliferation and reveals a suppressive role for Irf4 in TH2 polarization. Reducing Irf4 gene dosage leads to an increase in GATA3(+) and IL-4(+) cells. PMID: 28538176
  5. LAT and phospholipase C-gamma dephosphorylation by SHP-1 inhibits natural killer cell cytotoxicity. PMID: 27221712
  6. Single-molecule tracking studies have revealed that the LAT:Grb2:SOS assembly exhibits a characteristic transition to subdiffusive motion, indicating its dynamic structure resembles a loosely entangled polymer. PMID: 29045874
  7. Phosphotyrosine-mediated assembly of LAT adaptor protein networks yields two distinct kinetic species of the Ras activator SOS. PMID: 27370798
  8. Overexpression of LAT is associated with microcephaly. PMID: 28965845
  9. Upon T-cell receptor engagement, LAT and SLP-76 are randomly distributed throughout the forming clusters. PMID: 27875277
  10. Inherited LAT deficiency should be considered in patients with combined immunodeficiency characterized by T-cell abnormalities. PMID: 27522155
  11. This is the first reported case of a LAT-related disease in humans, presenting as a progressive combined immune deficiency with severe autoimmune disease. PMID: 27242165
  12. LAT1 plays a significant role in regulating the uptake of essential amino acids, such as leucine, into endometrial cancer cells. The ability of BCH to inhibit Ishikawa spheroid area, compared to LAT1 shRNA, suggests that other LAT family members may also contribute to cell growth. PMID: 27486861
  13. The SH2 domain of the T cell-specific adaptor protein (TSAd) interacts with CD6 antigen and LAT phosphotyrosine (pTyr) peptides. PMID: 27896837
  14. High expression of LAT1 and ASCT2 is correlated with metastasis and invasion in esophageal squamous cell carcinoma. PMID: 26936531
  15. IFT20 is essential for the delivery of the intracellular pool of LAT to the immune synapse in naive primary T lymphocytes. PMID: 26715756
  16. The palmitoylation mutation of LAT attenuated the signal transduction induced by glycosylphosphatidylinositol-anchored CD59 antigen in T cells. PMID: 26271970
  17. HSV-1-encoded Us3 protein disrupts TCR signaling and interleukin-2 production by inactivating the linker for activation of T cells. PMID: 25907557
  18. Patients with severe aplastic anemia exhibited elevated levels of LAT and a disturbed Th1-Th2 balance. PMID: 24673455
  19. LAT acts as a modulator of CD3zeta and ZAP-70 tyrosine phosphorylation. PMID: 24204825
  20. Mutation of the palmitoylation site of LAT-EGFP attenuated the signal transduction of CD59 in T cells. PMID: 24200054
  21. L-type amino acid transporter 1 (LAT1) is a major transporter for essential amino acids into activated human T cells. PMID: 24038088
  22. Histone hypoacetylation on the LAT promoter inhibits LAT expression and enhances Th2 differentiation. Conversely, trichostatin A, a histone deacetylase inhibitor, promotes LAT expression and inhibits Th2 cytokine production. PMID: 23360572
  23. LAT is required to maintain calcium homeostasis in T cells. PMID: 22998346
  24. TRAF6 plays a novel role in the TCR-LAT signaling pathway. LAT also acts as an adaptor molecule in TCR/CD28-induced activation of TRAF6. PMID: 23514740
  25. LAT located at the cell surface can be recruited efficiently to activation-induced microclusters within seconds of T-cell receptor (TCR) engagement. PMID: 23487428
  26. LAT cleavage may act as a regulator of TCR-mediated activation of T-cells, not solely as a transducer of cell death promoting stimuli. PMID: 23240581
  27. Expression of a constitutively active Raf transgene enhances lymphoproliferation, suggesting a role for the Ras-MAPK pathway in LAT-mediated autoimmune hyperproliferation. PMID: 22984075
  28. Nef, a protein encoded by HIV, employs a dual mechanism to disrupt early TCR signaling by limiting communication between LAT and SLP-76. PMID: 22802418
  29. Modeling and simulation of LAT aggregation with molecular variability in the number of binding sites for cytosolic Grb2-SOS1-Grb2 provides further insights into the process. PMID: 22396725
  30. The segment encompassing residues 112-126 of human LAT is essential for its interaction with Lck. PMID: 22034845
  31. Activation of T-cell antigen receptors results in the recruitment and phosphorylation of LAT from subsynaptic vesicles. Studies of LAT mutants confirm that recruitment precedes LAT phosphorylation. PMID: 21642986
  32. MAL regulates membrane order and the distribution of microtubule and transport vesicle docking machinery at the immune synapse, ensuring correct protein sorting of Lck and LAT to the cSMAC. PMID: 21508261
  33. PECAM-1-mediated inhibition of GPVI-dependent platelet responses arises from the recruitment of SHP-2-p85 complexes to tyrosine-phosphorylated PECAM-1, which diminishes the association of PI3K with activatory signaling molecules Gab1 and LAT. PMID: 20723025
  34. LAT recruits SLP-76 (Src homology 2 domain-containing leukocyte protein of 76 kDa) following T-cell receptor ligation and Akt kinase phosphorylation in Jurkat cells, activating the PI3K (phosphoinositide 3-hydroxykinase) signaling cascade. PMID: 21282515
  35. Elevated expression of LAT1 is associated with squamous cell carcinoma of the lung. PMID: 19068093
  36. LAT promotes TCR signal initiation and may contribute to maintaining active Lck in proximity to its substrates. PMID: 21152094
  37. LAT ubiquitylation acts as a molecular checkpoint for attenuating T-cell signaling. PMID: 21282648
  38. HSP90 acts as a positive regulator for LAT gene expression in activated T cells. PMID: 21251717
  39. LAT contains several conserved serine-based motifs crucial for proper signal transduction through the TCR. PMID: 20940326
  40. LAT is present in membrane rafts and is involved in signaling through various receptors besides the T-cell receptor. PMID: 20875087
  41. The significant decrease in mRNA expression of the LAT gene in T cells of asthmatic patients may be attributed to the up-regulation of its upstream regulatory factors Lck and ZAP-70. PMID: 18683785
  42. LAT displacement from lipid rafts is a molecular mechanism by which polyunsaturated fatty acids (PUFAs) inhibit T-cell signaling. PMID: 12029091
  43. Phosphorylation of LAT by Itk (IL-2 inducible T-cell kinase) promotes recruitment of Vav, a guanine nucleotide exchange factor. PMID: 12186560
  44. LAT plays a role in signal transduction for T-cell activation and is stably associated with plasma membrane rafts. PMID: 12515827
  45. The interaction with the open-active form of Lck in lipid rafts reveals a novel mechanism for regulating Lck in T cells. PMID: 12570875
  46. Examination of synergistic assembly in T-cell plasma membrane domains provides further insights into signaling processes. PMID: 12646565
  47. LAT is required for the correct orientation of the microtubule-organizing center as it moves towards the interface of the T cell and antigen-presenting cell. PMID: 12847255
  48. Studies have elucidated the basis for preferential recognition of specific LAT sites by Gads, an adapter protein. PMID: 15029250
  49. CD3/T-cell receptor complex signaling to β1 integrins is defective in LAT-deficient Jurkat T cells and can be restored by expressing wild-type LAT. PMID: 15100278
  50. LAB resembled a LAT molecule incapable of binding phospholipase C-gamma1. PMID: 15153499

Show More

Hide All

Database Links

HGNC: 18874

OMIM: 602354

KEGG: hsa:27040

UniGene: Hs.632179

Involvement In Disease
Immunodeficiency 52 (IMD52)
Subcellular Location
Cell membrane; Single-pass type III membrane protein. Note=Present in lipid rafts.
Tissue Specificity
Expressed in thymus, T-cells, NK cells, mast cells and, at lower levels, in spleen. Present in T-cells but not B-cells (at protein level).

Q&A

What is the biological significance of LAT Y191 phosphorylation in T cell signaling?

LAT (Linker for Activation of T cells) is a palmitoylated and membrane-associated adaptor protein that plays a crucial role in T cell receptor (TCR) signaling. Upon TCR stimulation, LAT becomes phosphorylated at multiple tyrosine residues, including Y191, by ZAP-70 kinase . Phosphorylation at Y191 is essential for the assembly of TCR-coupled signaling complexes that mediate productive T cell activation. This phosphorylation event serves as a docking site for specific signaling proteins, contributing to the formation of the LAT signalosome, which orchestrates downstream signaling pathways crucial for T cell function .

Research has shown that phosphorylation at Y191, along with other tyrosine residues (Y132, Y171, and Y226), creates binding sites for various signaling molecules, including Grb2, Gads, and indirectly PLC-γ1 . These interactions are critical for multiple downstream signaling events, including calcium mobilization, MAPK activation, and eventual transcriptional responses that determine T cell fate.

How does phosphorylation at Y191 differ functionally from other LAT phosphorylation sites?

LAT contains multiple tyrosine phosphorylation sites, each playing distinct roles in the recruitment of signaling proteins and subsequent downstream events:

Phosphorylation SitePrimary Binding PartnersDownstream Functions
Y132PLC-γ1Calcium mobilization, PKC activation
Y171Grb2, GadsRas/MAPK pathway activation
Y191Grb2, GadsSOS recruitment, Ras activation
Y226Grb2Enhances signaling complex formation

Unlike Y132, which is the only residue in LAT that directly recruits PLC-γ1 upon phosphorylation , Y191 primarily interacts with adaptor proteins like Grb2 and Gads. Notably, phospho-Y191 contributes to the recruitment of the Ras activator SOS, which is critical for downstream MAPK pathway activation .

Research has demonstrated that while single tyrosine mutations at Y191 show some level of phosphorylation, a single phosphorylated Y191 is insufficient for proper association with signaling proteins like Grb2, suggesting that multiple phosphorylated tyrosines work cooperatively to establish functional signaling complexes .

What are the standard applications for using Phospho-LAT (Y191) antibodies in research?

Phospho-LAT (Y191) antibodies can be utilized in various experimental approaches to investigate T cell activation and signaling:

ApplicationRecommended DilutionKey Considerations
Western Blot (WB)1:500-1:5000Effective for quantifying phosphorylation levels
Immunohistochemistry (IHC)1:50-1:200Visualizes spatial distribution in tissues
Immunofluorescence (IF)1:20-1:200Examines subcellular localization
Immunoprecipitation (IP)1:200-1:1000Isolates LAT complexes for interaction studies

For optimal results, it's recommended to use freshly prepared samples as phosphorylation states can degrade rapidly. When designing experiments, consider including appropriate positive controls (TCR-stimulated T cells) and negative controls (unstimulated cells or phosphatase-treated samples) . Time-course experiments are particularly valuable for understanding the kinetics of Y191 phosphorylation relative to other tyrosine residues.

How does phosphorylation at Y191 contribute to the formation and stability of the LAT signalosome?

Phosphorylation of LAT at Y191 is a critical component in the hierarchical assembly of the LAT signalosome. Recent research has revealed that phospho-Y191 serves as a docking site primarily for Grb2 and Gads adaptor proteins, which subsequently recruit additional signaling molecules . The formation of the LAT signalosome follows a complex, ordered process where multiple phosphorylated tyrosines cooperate to create a stable signaling hub.

Importantly, studies using membrane reconstitution systems have demonstrated that phosphorylated LAT, in the presence of Grb2 and the proline-rich domain of SOS, forms macroscopic network assemblies on membranes . These assemblies create protein-dense phases with an estimated density of ~4,000 molecules per square micron. FRAP experiments have shown that these assemblies are dynamic, with fluorescence recovery after photobleaching occurring with an effective diffusion coefficient of 0.20 μm²/s, indicating continuous exchange of components within the complex .

The stability of these LAT signalosome assemblies is dependent on multiple tyrosine phosphorylation events, as evidenced by:

  • The requirement for kinase-dependent LAT phosphorylation for assembly formation

  • The failure of LAT mutants with single phosphotyrosine sites to form assemblies under the same conditions

  • The rapid reversal of assembly when tyrosine phosphatase (YopH) is introduced

These findings suggest that Y191 phosphorylation, in concert with other phosphotyrosine sites, creates a multivalent interaction network that drives phase separation of signaling components, facilitating efficient signal propagation.

What is the relationship between phosphorylation kinetics at Y191 and T cell activation thresholds?

The kinetics of LAT phosphorylation at different tyrosine residues significantly impact T cell activation thresholds and ligand discrimination. While research has specifically highlighted Y132 as a critical kinetic bottleneck for ligand discrimination , phosphorylation at Y191 also plays an important role in modulating T cell responsiveness.

Studies have shown that alterations in phosphorylation kinetics can significantly affect T cell activation thresholds. For example, mutations that enhance phosphorylation rates at critical LAT tyrosine residues lead to lower TCR response thresholds and amplified T cell responsiveness . Time-course experiments have demonstrated that accelerated phosphorylation kinetics directly correlate with enhanced downstream signaling events .

In the context of the LAT signalosome, the kinetics of Y191 phosphorylation influence:

  • The temporal assembly of the signalosome components

  • The duration of signaling complex stability

  • The threshold of antigen stimulation required for productive T cell activation

  • The qualitative nature of the T cell response

Recent work has revealed that phosphorylation of LAT serines (S224 and S241) is also essential for the subsequent phosphorylation of tyrosine residues, including Y191 . This hierarchical phosphorylation cascade creates a sophisticated system for temporal control of signaling.

How do serine phosphorylation events in LAT affect Y191 phosphorylation and signaling outcomes?

Recent research published in 2025 has uncovered an intriguing relationship between serine phosphorylation in LAT and subsequent tyrosine phosphorylation events. DNA-PKcs (DNA-dependent protein kinase catalytic subunit) has been identified as a key regulator of LAT phosphorylation at serine residues S224 and S241 .

Critical findings regarding this relationship include:

  • Phosphorylation at S224 and S241 is required for the phosphorylation of LAT tyrosine residues Y132, Y171, and Y191

  • LAT mutants with serine-to-alanine mutations at S241 (S241A) or both S224 and S241 (S2A) prevented tyrosine phosphorylation at Y132, Y171, and Y191

  • Mutation at S241 significantly alters the protein composition of the LAT signalosome

Mechanistically, these serine phosphorylation events appear to create a permissive state for subsequent tyrosine phosphorylation by ZAP70. Interestingly, while DNA-PKcs inhibition with NU7441 did not block tyrosine phosphorylation, pan-PI3K inhibition with LY294002 did block phosphorylation at Y132, Y171, and Y191, suggesting multiple kinases may phosphorylate these serine residues .

The functional consequences of these serine phosphorylation events are significant:

MutationEffect on Tyrosine PhosphorylationEffect on Protein BindingFunctional Outcome
S224AMinimal effectAltered binding patternImpaired IL-2 production
S241APrevented Y132/Y171/Y191 phosphorylationSignificant decrease in signalosome formationImpaired IL-2 production
S2A (double)Prevented Y132/Y171/Y191 phosphorylationSignificant decrease in signalosome formationImpaired IL-2 production

These findings highlight the complex interdependence of phosphorylation events in LAT and underscore the importance of considering both serine and tyrosine phosphorylation when studying LAT signaling dynamics .

What are the optimal experimental conditions for detecting Phospho-LAT (Y191) in different cellular systems?

Detecting phospho-LAT (Y191) requires careful consideration of experimental conditions to preserve the phosphorylation state and maximize signal-to-noise ratio. Here are optimal approaches for different experimental systems:

For Primary T Cells:

  • Stimulation conditions: Use anti-CD3/CD28 antibodies (typically 10 μg/ml) for 1-3 minutes to achieve robust Y191 phosphorylation

  • Cell lysis: Employ rapid lysis in buffer containing phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate)

  • Sample processing: Maintain samples at 4°C throughout processing to minimize dephosphorylation

  • Positive controls: Include cells treated with pervanadate to maximize phosphorylation levels

For Jurkat T Cell Lines:
Similar protocols apply, but with some modifications:

  • Stimulation can be performed with anti-CD3 antibodies (such as C305)

  • Lower antibody concentrations may be sufficient due to generally higher expression levels of signaling components

For In Vitro Reconstitution Systems:
When using purified components:

  • LAT can be phosphorylated by membrane-tethered Src family kinase Hck or ZAP70

  • Phosphorylation can be monitored in real-time using fluorescently-labeled Grb2 recruitment

  • For membrane reconstitution, a pLAT density of approximately 2,400 molecules per square micron is effective for visualizing signalosome formation

Detection Methods Comparison:

MethodSensitivityQuantificationSpatial InformationKey Considerations
Western BlotHighSemi-quantitativeNoneUse BSA blocking to reduce background
Flow CytometryModerateQuantitativeNoneRequires careful fixation/permeabilization
MicroscopyModerate-HighSemi-quantitativeHighAllows visualization of signalosome formation
Mass SpectrometryVery HighQuantitativeNoneCan detect multiple phosphorylation sites

For all methods, inclusion of appropriate controls is essential, including phosphatase-treated negative controls and comparison with total LAT antibody to normalize for expression levels .

How can Phospho-LAT (Y191) antibodies be integrated with other techniques to comprehensively analyze T cell signaling?

For comprehensive analysis of T cell signaling, Phospho-LAT (Y191) antibodies can be strategically combined with complementary techniques:

Multiparameter Flow Cytometry:
Combine phospho-LAT (Y191) detection with antibodies against other phosphorylated signaling molecules (pZAP70, pPLC-γ1, pERK) to assess signaling pathway activation at the single-cell level. This approach allows correlation of Y191 phosphorylation with downstream events and can reveal heterogeneity in cellular responses.

Microscopy-Based Approaches:

  • TIRF Microscopy: Particularly valuable for visualizing LAT signalosome formation at the plasma membrane, as demonstrated in studies showing macroscopic protein-dense phases of pLAT assemblies

  • FRAP Analysis: Assess mobility and dynamics of LAT signalosome components following Y191 phosphorylation

  • Proximity Ligation Assay (PLA): Detect specific interactions between phospho-LAT (Y191) and binding partners like Grb2

Biochemical Approaches:

  • Immunoprecipitation followed by Mass Spectrometry: Identify novel interaction partners of phospho-LAT (Y191)

  • Phospho-specific Protein Microarrays: Profile multiple phosphorylation events simultaneously

Genetic Approaches:

  • CRISPR-Cas9 Mediated Mutagenesis: Generate Y191F mutants to assess functional consequences

  • Reconstitution Systems: Express WT or mutant LAT in LAT-deficient cell lines like J.LAT to assess specific contributions of Y191

Integrative Data Analysis:
Computational approaches can integrate data from multiple techniques to build comprehensive signaling network models:

TechniqueInformation ProvidedIntegration Strategy
Phospho-flowQuantitative signaling kineticsCorrelate with functional outcomes
ImagingSpatial organizationMap signalosome assembly patterns
ProteomicsInteraction partnersBuild network models
Functional assaysDownstream outcomesConnect signaling to function

This multi-technique approach enables researchers to connect Y191 phosphorylation to both molecular events (protein recruitment) and functional outcomes (cytokine production, proliferation) .

What controls are essential when working with Phospho-LAT (Y191) antibodies?

When working with phospho-specific antibodies like Phospho-LAT (Y191), rigorous controls are essential to ensure reliable and interpretable results:

Essential Negative Controls:

  • Unstimulated Cells: Provide baseline phosphorylation levels

  • Phosphatase-Treated Samples: Treatment with tyrosine phosphatase (e.g., YopH at 10 μM) confirms signal specificity for phosphorylated epitopes

  • Y191F Mutant LAT: Expression of LAT with tyrosine-to-phenylalanine mutation at position 191 serves as a genetic negative control

  • LAT-Deficient Cells: J.LAT cells or similar LAT-deficient cell lines provide background control

  • Isotype Control Antibody: Controls for non-specific antibody binding

Essential Positive Controls:

  • Pervanadate Treatment: A potent phosphatase inhibitor that maximizes phosphorylation

  • TCR Stimulation Time Course: Shows the expected kinetic profile of Y191 phosphorylation

  • Reconstituted Cells: LAT-deficient cells reconstituted with wild-type LAT and stimulated via TCR

Specificity Controls:

  • Peptide Competition: Pre-incubation of antibody with phosphorylated Y191 peptide should abolish specific signal

  • Multiple Detection Methods: Confirm phosphorylation using alternative techniques (e.g., mass spectrometry)

  • Antibody Validation: Western blot showing a single band at the expected molecular weight of LAT (~36-38 kDa)

Quantification Controls:

  • Total LAT Detection: Always probe for total LAT protein to normalize phosphorylation signals

  • Loading Controls: Use housekeeping proteins (β-actin, GAPDH) to ensure equal protein loading

  • Concentration Series: Perform antibody dilution series to ensure operation in the linear range of detection

Implementing these controls will significantly enhance data reliability and facilitate proper interpretation of experimental results when using Phospho-LAT (Y191) antibodies in T cell signaling research .

How can researchers resolve contradictory results when studying LAT Y191 phosphorylation?

When researchers encounter contradictory results regarding LAT Y191 phosphorylation, several methodological approaches can help resolve these discrepancies:

Common Sources of Contradiction and Resolution Strategies:

  • Antibody Specificity Issues:

    • Verify antibody specificity using Y191F mutants as negative controls

    • Compare results using antibodies from different sources/clones

    • Confirm specificity through peptide competition assays

  • Temporal Discrepancies:

    • LAT phosphorylation is highly dynamic, with Y191 phosphorylation occurring with specific kinetics

    • Perform detailed time-course experiments (0-30 minutes) with early time points (15s, 30s, 1min) to capture rapid changes

    • Compare stimulation protocols across studies to identify timing differences

  • Cell Type Variations:

    • LAT phosphorylation patterns differ between primary T cells and cell lines

    • Note that LAT is more highly expressed in human T cells than mouse T cells, potentially affecting functional impact

    • When comparing studies, carefully consider cell type differences

  • Upstream Signaling Differences:

    • Y191 phosphorylation depends on upstream events, including serine phosphorylation at S224/S241

    • Verify activation status of ZAP70, which directly phosphorylates LAT tyrosines

    • Consider potential crosstalk with PI3K pathway, as PI3K inhibition blocks LAT tyrosine phosphorylation

  • Technical Considerations:

    • Phosphorylation can be lost during sample preparation

    • Standardize lysis conditions with appropriate phosphatase inhibitors

    • Consider orthogonal techniques (e.g., mass spectrometry) to validate phosphorylation status

Analysis Approach for Resolving Contradictions:

Contradiction TypeInvestigation ApproachValidation Method
Presence/absence of phosphorylationTime course with multiple detection methodsIndependent detection techniques
Kinetics differencesHigh-resolution time courseCompare with known phosphorylation events
Functional impact differencesReconstitution with WT vs Y191F LATAssess multiple downstream readouts
Cell-type specific differencesDirect comparison across cell typesControl for expression level differences

When published results conflict with your findings, systematically examine methodological differences in stimulation conditions, cell types, detection methods, and time points to identify the source of discrepancy .

What are the key considerations for quantitative analysis of LAT Y191 phosphorylation?

Quantitative analysis of LAT Y191 phosphorylation requires careful attention to several methodological factors to ensure accurate and reproducible measurements:

Sample Preparation Considerations:

  • Rapid sample processing to preserve phosphorylation status

  • Consistent cell numbers and stimulation conditions across experiments

  • Complete denaturation of samples for accurate antibody binding

Normalization Strategies:
For Western blot analysis:

  • Always normalize phospho-LAT (Y191) signal to total LAT protein

  • Avoid normalizing to housekeeping proteins alone, as they don't account for variations in LAT expression

  • Consider using the ratio of phospho-Y191 to other phosphorylation sites (e.g., Y171) to assess relative phosphorylation patterns

Quantification Methods Comparison:

MethodAdvantagesLimitationsBest Practices
Western Blot DensitometryWidely accessibleSemi-quantitativeUse standard curves with known quantities
Flow CytometrySingle-cell resolutionRequires specific validationInclude fluorescence standards
ELISAHigh sensitivityLimited spatial informationGenerate standard curves for each experiment
Mass SpectrometryAbsolute quantification possibleRequires specialized equipmentUse isotope-labeled standards

Statistical Analysis:

  • Use appropriate statistical tests based on data distribution

  • For time-course experiments, consider area-under-curve analysis

  • For concentration-response studies, calculate EC50 values for stimulation thresholds

  • When comparing multiple conditions, correct for multiple comparisons

Reporting Standards:

  • Always include both representative images/plots and quantification

  • Report both raw values and normalized data

  • Clearly state sample sizes and number of independent experiments

  • Specify the statistical methods and significance thresholds used

Advanced Quantification Approaches:

  • Quantify the ratio of membrane-associated versus cytosolic phospho-LAT to assess translocation

  • In imaging studies, assess colocalization coefficients between phospho-LAT (Y191) and binding partners

  • For signalosome studies, quantify cluster size, density, and lifetime

Following these guidelines will enhance the reliability and reproducibility of quantitative analyses of LAT Y191 phosphorylation in T cell signaling research .

How does LAT Y191 phosphorylation contribute to differential signaling outcomes in CD4+ versus CD8+ T cells?

Recent research has revealed intriguing differences in how LAT signaling, including Y191 phosphorylation, contributes to functional outcomes in CD4+ versus CD8+ T cells:

Differential Functional Impacts:
Studies using conditional knockout mouse models (Cre+CD4-PKcsfl/fl and Cre+CD8-PKcsfl/fl) have demonstrated that disruption of DNA-PKcs, a kinase that influences LAT phosphorylation, has more pronounced effects on CD8+ T cells compared to CD4+ T cells . Specifically:

These findings suggest that the LAT signalosome, to which phospho-Y191 contributes, may play differential roles in the helper functions of CD4+ T cells versus the cytotoxic functions of CD8+ T cells .

Mechanistic Differences:
Several factors may contribute to these differential outcomes:

  • Expression Level Differences:

    • LAT is more highly expressed in human T cells than mouse T cells

    • Expression levels may vary between T cell subsets, affecting signaling thresholds

  • Signalosome Composition:

    • Different adaptor proteins may preferentially interact with phospho-Y191 in CD4+ versus CD8+ T cells

    • The stoichiometry of signaling components may vary between cell types

  • Temporal Dynamics:

    • The kinetics of Y191 phosphorylation may differ between T cell subsets

    • Temporal differences in signalosome assembly may drive distinct functional outcomes

  • Integration with Other Pathways:

    • CD8+ T cells may rely more heavily on LAT-dependent pathways for cytotoxic function

    • CD4+ T cells may have redundant signaling mechanisms that compensate for LAT signaling deficiencies

Research Implications:
When studying LAT Y191 phosphorylation, researchers should:

  • Separately analyze CD4+ and CD8+ T cells rather than bulk T cells

  • Consider potential differences in phosphorylation kinetics between subsets

  • Examine multiple functional readouts relevant to each cell type (cytokine production for CD4+, cytotoxicity for CD8+)

  • Account for potential species differences when translating findings between mouse and human systems

Understanding these differential effects will provide deeper insights into how common signaling components like LAT can be regulated to produce distinct functional outcomes in different T cell populations .

How do recent findings about LAT serine phosphorylation impact our understanding of Y191 function?

Recent research published in 2025 has revealed critical new insights into the regulation of LAT tyrosine phosphorylation through previously underappreciated serine phosphorylation events:

DNA-PKcs has been identified as a kinase that mediates phosphorylation of LAT at serine residues S224 and S241 . This serine phosphorylation has profound effects on subsequent tyrosine phosphorylation, including at Y191. Key findings include:

  • Phosphorylation at S224 and S241 is essential for the phosphorylation of LAT tyrosines Y132, Y171, and Y191

  • LAT mutants lacking these serine phosphorylation sites (S241A or S2A) fail to undergo tyrosine phosphorylation upon T cell activation

  • These serine phosphorylation events significantly impact protein binding to LAT and downstream signaling outcomes

This hierarchical phosphorylation model represents a paradigm shift in our understanding of LAT signaling regulation, suggesting that:

  • Serine phosphorylation creates a permissive state for subsequent tyrosine phosphorylation

  • The LAT signalosome assembly is regulated at multiple levels beyond tyrosine phosphorylation

  • Y191 function must be considered in the context of this broader phosphorylation network

Future research directions should explore:

  • The precise structural changes induced by serine phosphorylation that facilitate Y191 phosphorylation

  • The temporal relationship between serine and tyrosine phosphorylation events

  • How these serine phosphorylation events are regulated by upstream signaling pathways

  • The potential for targeting serine phosphorylation as a means to modulate T cell responses

What are the emerging applications of Phospho-LAT (Y191) antibodies in clinical and translational research?

While Phospho-LAT (Y191) antibodies have primarily been used in basic research settings, several emerging applications show promise for clinical and translational research:

Biomarker Development:

  • T cell activation status assessment in autoimmune diseases

  • Monitoring treatment response to immunomodulatory therapies

  • Identifying signaling defects in primary immunodeficiencies

Cancer Immunotherapy Monitoring:

  • Evaluating CAR-T cell product quality by assessing signaling capacity

  • Monitoring T cell activation status in tumor microenvironments

  • Predicting response to immune checkpoint inhibitors based on T cell signaling potential

Precision Medicine Applications:

  • Identifying patient-specific signaling defects in T cell-mediated diseases

  • Tailoring immunomodulatory treatments based on LAT phosphorylation patterns

  • Developing companion diagnostics for immunotherapies

Emerging Technical Approaches:

  • Single-cell phospho-proteomics to assess Y191 phosphorylation at the individual cell level

  • In vivo imaging of T cell activation using phospho-specific probes

  • Development of biosensors for real-time monitoring of LAT phosphorylation dynamics

Translational Research Considerations:

ApplicationTechnical RequirementsClinical Relevance
Diagnostic testingStandardized assays with clinical validationIdentifying signaling defects
Prognostic biomarkerLongitudinal monitoring capabilitiesPredicting treatment response
Therapeutic targetingDevelopment of modulators of LAT phosphorylationNovel immunomodulatory approaches

As research continues to elucidate the role of LAT phosphorylation in T cell biology, these translational applications will likely expand, offering new opportunities for clinical application of basic immunological research .

What methodological advances have improved detection specificity and sensitivity for LAT Y191 phosphorylation?

Recent technological and methodological advances have significantly enhanced our ability to detect and quantify LAT Y191 phosphorylation with improved specificity and sensitivity:

Antibody Technology Improvements:

  • Recombinant Monoclonal Antibodies: The development of recombinant antibodies, such as the Phospho-LAT (Y191) recombinant monoclonal antibody, provides greater batch-to-batch consistency and specificity compared to conventional antibodies

  • Rabbit Monoclonal Platforms: Rabbit-derived monoclonal antibodies often demonstrate superior sensitivity and specificity for phospho-epitopes compared to mouse-derived antibodies

  • Validation Strategies: Comprehensive validation using phosphatase treatment, Y191F mutants, and knockout controls ensures antibody specificity

Advanced Detection Methods:

  • Proximity Ligation Assay (PLA): Enables detection of phospho-LAT in situ with improved sensitivity by amplifying signals only when two antibodies (e.g., anti-LAT and anti-phosphotyrosine) are in close proximity

  • Single-Molecule Imaging: Techniques like stochastic optical reconstruction microscopy (STORM) allow visualization of individual LAT molecules and their phosphorylation status

  • Mass Cytometry (CyTOF): Combines flow cytometry with mass spectrometry to enable highly multiplexed analysis of phosphorylation events, including LAT Y191

Sample Preparation Innovations:

  • Optimized Fixation Protocols: Rapid fixation methods that better preserve phosphorylation states

  • Phosphatase Inhibitor Formulations: More effective cocktails to prevent dephosphorylation during sample processing

  • On-chip Processing: Microfluidic devices that enable stimulation, fixation, and antibody labeling with minimal sample handling

Quantification Approaches:

  • Multiple Reaction Monitoring (MRM): Targeted mass spectrometry enables absolute quantification of phosphopeptides containing Y191

  • Digital ELISA Platforms: Technologies like Simoa provide femtomolar sensitivity for protein detection

  • Automated Image Analysis: Machine learning algorithms improve quantification of phospho-LAT in microscopy images

Multiplexed Analysis:

  • Spectral Flow Cytometry: Allows simultaneous detection of multiple phosphorylation sites on LAT and other signaling proteins

  • Multiplexed Ion Beam Imaging (MIBI): Enables spatial mapping of multiple phosphorylation events at subcellular resolution

  • Phospho-proteomics: Advances in mass spectrometry techniques allow comprehensive profiling of LAT phosphorylation alongside hundreds of other phosphorylation events

These methodological advances have collectively improved our ability to detect LAT Y191 phosphorylation with greater specificity, sensitivity, and contextual information, enabling more sophisticated studies of T cell signaling dynamics .

What is the current consensus on the role of LAT Y191 phosphorylation in T cell biology?

Based on the current literature, the scientific consensus on LAT Y191 phosphorylation centers around several key points:

  • Hierarchical Phosphorylation Model:
    LAT phosphorylation follows a hierarchical pattern, with serine phosphorylation at S224 and S241 creating a permissive state for subsequent tyrosine phosphorylation at Y132, Y171, and Y191 by ZAP70 . This multi-step process ensures proper regulation of T cell signaling.

  • Cooperative Signaling:
    While Y191 is an important phosphorylation site, it functions cooperatively with other tyrosine residues. Research has clearly demonstrated that single phosphorylated tyrosine residues, including Y191, are insufficient for proper signalosome assembly and downstream signaling .

  • Adaptor Binding Specificity:
    Phosphorylated Y191 primarily serves as a docking site for the adaptor proteins Grb2 and Gads, which subsequently recruit additional signaling molecules including SOS . This specificity determines the downstream signaling pathways activated.

  • Signalosome Architecture:
    Phosphorylated LAT, including p-Y191, drives the formation of macroscopic network assemblies on membranes, creating protein-dense phases that facilitate signaling complex formation and stability . These assemblies are dynamic and regulated by the phosphorylation state of LAT.

  • Differential Impact in T Cell Subsets:
    The LAT signalosome, to which p-Y191 contributes, appears to have differential impacts on CD4+ versus CD8+ T cells, with potentially greater functional importance in cytotoxic CD8+ T cell responses .

  • Temporal Regulation:
    The kinetics of Y191 phosphorylation contribute to T cell activation thresholds and antigen discrimination, with alterations in phosphorylation rates affecting T cell responsiveness .

The current model places LAT Y191 phosphorylation as a critical node in a complex signaling network, requiring both upstream serine phosphorylation and cooperative interactions with other phosphotyrosine residues to orchestrate effective T cell responses .

What are the most significant unanswered questions regarding LAT Y191 phosphorylation?

Despite significant advances in our understanding of LAT Y191 phosphorylation, several important questions remain unanswered:

  • Structural Basis of Hierarchical Phosphorylation:

    • How do serine phosphorylation events at S224 and S241 structurally facilitate subsequent Y191 phosphorylation?

    • Does phosphorylation induce conformational changes that expose Y191 to ZAP70?

  • Temporal Dynamics and Order of Phosphorylation:

    • What is the precise order and timing of phosphorylation events at different LAT residues?

    • How do the kinetics of Y191 phosphorylation compare to other tyrosine residues in different activation contexts?

  • Regulation of Phosphatases:

    • Which phosphatases specifically target Y191, and how are they regulated during T cell activation?

    • How does the balance between kinase and phosphatase activity fine-tune Y191 phosphorylation?

  • Cell-Type Specific Functions:

    • Why does LAT signaling appear to have differential impacts on CD4+ versus CD8+ T cells?

    • How does Y191 phosphorylation contribute to different functional outcomes in various T cell subsets?

  • Spatial Organization:

    • How is Y191 phosphorylation spatially organized within the immunological synapse?

    • Are there microclusters or domains with different densities of phospho-Y191?

  • Integration with Other Signaling Pathways:

    • How does Y191 phosphorylation interact with other signaling pathways, such as costimulatory signals?

    • Are there undiscovered molecules that bind to phospho-Y191 in specific contexts?

  • Pathological Significance:

    • Are there diseases associated with alterations in Y191 phosphorylation?

    • Could targeting Y191 phosphorylation have therapeutic potential?

  • Species Differences:

    • Given that LAT expression levels differ between mouse and human T cells , are there species-specific differences in Y191 phosphorylation and its functional consequences?

  • Single-Cell Heterogeneity:

    • How variable is Y191 phosphorylation at the single-cell level, and what are the functional consequences of this heterogeneity?

    • Do subpopulations of T cells show distinct patterns of LAT phosphorylation?

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.